prospective and longitudinal registry study, we assess patients receiving electroconvulsive therapy (ECT) systematically at several time points. The aim of the study is to investigate the influence of clinical [...] of the prospective and longitudinal study is to identify possible predictors of therapy response. Research project 5 ESCAPE-DTD In this clinical trial (Phase IIIB study), the efficacy, safety and tolerability [...] Eberle F, Bleich S, Neyazi A, Frieling H. Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy. Clin Epigenetics

Investigators KORA Study Group Cooperative Health Research in the Region of Augsburg (KORA) Study Group Global BPgen Consortium, Diabetes Genetics Replication and Meta-analyses (DIAGRAM+) Study International [...] population based and disease related epidemiological studies (e.g. KORA, Augsburg Diabetes Family Study). One main focus is the molecular analysis of cardiovascular and metabolic diseases mainly of type [...] 1992 - 1995 PhD in Cell Biology, O-Glycosilation in yeast, University of Regensburg 1986 - 1991 Study of biology, University of Regensburg Professional Experience Since 01/2012 CEO and scientific head

Headline Subline Titel A multicenter, randomized, double-blind, placebo-controlled study to demonstrate that digitoxin reduces a composite of overall mortality and hospitalization for worsening heart failure [...] in Patients with Advanced Chronic Heart Failure): A Randomized, Double‐blind, Placebo‐controlled Study.” European Journal of Heart Failure 21(5):676–84. doi: 10.1002/ejhf.1452. Großhennig, Anika , and

von Corona-Virusinfektion und -Pandemie DEFEnse Against COVID-19 STudy – Looking forward DEFEAT Corona - DEFEnse Against COVID-19 STudy – Looking forward- ist ein EU-gefördertes Forschungsprojekt, das

In order to reduce this data gap, the 'Sex@Brain Study' was initiated in the clinical psychology and sexual medicine department. The aim of this study is to examine the clinical, neuropsychological and [...] However, to date there is no form of drug therapy that has official approval for BPS. In the clinical study 'Botulinum Toxin for the Treatment of Borderline Personality Disorder', IncobotulinumtoxinA (colloquially [...] motivated by a pedophile. Imaging, psychometric and physiological methods are used here. The special study design is intended to deepen the understanding of the distinction between sexual preference and sexual

paediatric physical therapy practice worldwide: a feasibility study. Online Report 2022: https://labo-grandir.com/wp-content/uploads/2022/04/SCOOPPP-Study-Survey-development-report.pdf Camden C, Mulligan H, Cinar [...] of brain injured patients undergoing early neurological rehabilitation: a prospective observation study. BMC Neurology 2022; 22. DOI: https://doi.org/10.1186/s12883-022-02549-w Boltzmann M, Schmidt SB, [...] Screening of Patient Impairments in an Outpatient Clinic for Suspected Rare Diseases-A Cross-Sectional Study. Int J Environ Res Public Health 2022; 19(14): 8874; DOI: https://doi.org/10.3390/ijerph19148874

Georgii A, Loeffler M: BEACOPP: A new regimen for advanced Hodgkin's disease German Hodgkin Lymphoma Study Group. Ann Oncol 1998; 9 (Suppl 5): 67-71 Diehl V, Franklin J, Hasenclever D, Tesch H, Pfreundschuh [...] with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's lymphoma Study Group. J Clin Oncol 1998; 16(12): 3810-21 Duensing S, Duensing A, Grosse J, Atzpodien J: Loss of VLA-3 [...] Pichlmayr R: Asanguineous isolated hyperthermic perfusion of the liver: results of an experimental study in pigs. Recent Results Cancer Res 1998; 147: 19-27 Michel K, Roth S, Trautwein C, Gong W, Flemming

detachment with inferior breaks: VIPER Study Report No. 3 . Baumgarten S, Schiller P, Hellmich M, Walter P, Agostini H, Junker B , Helbig H, Lommatzsch A, Mazinani B, VIPER Study Group. Graefes Arch Clin Exp Ophthalmol [...] extension study . Feltgen N, Hattenbach LO, Bertelmann T, Callizo J, Rehak M, Wolf A, Berk H, Eter N, Lang GE, Pielen A , Schmitz-Valckenberg S, Quiering C, Rose U, Hoerauf H, COMRADE Study Group. Acta [...] Label Study. Hoerauf H, Feltgen N, Weiss C, Paulus EM, Schmitz-Valckenberg S, Pielen A , Puri P, Berk H, Eter N, Wiedemann P, Lang GE, Rehak M, Wolf A, Bertelmann T, Hattenbach LO, COMRADE-C Study Group

cohort study. Z Gerontol Geriatr. 2020 Nov;53(7):663-670. Junius-Walker U , Schleef T, Vogelsang U, Dierks ML. How older patients prioritise their multiple health problems. A qualitative study. BMC Geriatrics [...] U , Schleef, T, Donner-Banzhoff N, Viniol A. MediQuit–an electronic deprescribing tool: a pilot study in German primary care; GPs’ and patients’ perspectives. BMC primary care 2022; 23:252. Rudolf H, [...] MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General Practice. Drugs Aging. 2021 Aug;38(8):725-733. Greten S, Müller-Funogea JI, Wegner

Tetzlaff J (2020). The effects of different lookback periods on the sociodemographic structure of the study population and on the estimation of incidence rates: analyses with German claims data. BMC Medical [...] Epping J (2019). Health inequalities in terms of myocardial infarction and all-cause mortality: a study with German claims data covering 2006 to 2015. International Journal of Public Health. 2019;64(3):387-97 [...] myocardial infarction 2006 to 2015 in terms of changing rates and age at occurrence: A longitudinal study using claims data from Germany. PloS one. 2018;13(8):e0202631. Memaran N, Kirchner M, Blote R, Ma